Position in HLN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$589,795
-$53,647 QoQ
Shares Held
63,215
-1.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#178
of 640 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Argent Trust Co holds $2,076,296 across 3 Drug Manufacturers - Specialty & Generic names. HLN ranks #2 (28.4% of the industry book) .
All Filings in HLN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $589,795 | 63,215 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $643,442 | 64,280 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $559,769 | 55,368 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $451,163 | 50,297 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $537,362 | 51,819 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $443,971 | 43,146 | Shares | Other | 2025-05-09 | |
| 2024-12-31 | $285,055 | 29,880 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $159,451 | 15,071 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $109,007 | 13,197 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $112,042 | 13,197 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $148,378 | 18,029 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $186,183 | 22,351 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $204,228 | 24,371 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $223,174 | 27,417 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $296,568 | 37,071 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $239,854 | 39,385 | Shares | Defined | 2022-11-10 | |
| No filing history on record for this holder in this stock. | ||||||